An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes
10.2337/db13-0800
Saved in:
Main Authors: | Noonan, J.E., Jenkins, A.J., Ma, J.-X., Keech, A.C., Wang, J.J., Lamoureux, E.L. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Review |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/128663 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: Baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]
by: Keech, A.C, et al.
Published: (2020) -
Fenofibrate: A new treatment for diabetic retinopathy. molecular mechanisms and future perspectives
by: Simó, R., et al.
Published: (2014) -
Fenofibrate - A potential systemic treatment for diabetic retinopathy?
by: Wong, T.Y., et al.
Published: (2014) -
Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow
by: Nguyen, T.T., et al.
Published: (2014) -
Ocular associations of diabetes other than diabetic retinopathy
by: Jeganathan, V.S.E., et al.
Published: (2011)